Stockreport

Sanofi reports positive data from Phase III EoE treatment trial [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The study is designed to evaluate the efficacy and safety of Dupixent in these children. A fully human monoclonal antibody, Dupixent targets the interleukin-4 (IL4) a [Read more]